Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Rochester
University of Washington
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
West Virginia University
The University of Queensland
Technical University of Munich
Kousai Bio Co., Ltd.
Universität Duisburg-Essen
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
University of Florida
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
Calibr, a division of Scripps Research
City of Hope Medical Center
University of Arizona
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Ruijin Hospital
Nationwide Children's Hospital
Milton S. Hershey Medical Center
University of Wisconsin, Madison
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
University of Chicago
Wake Forest University Health Sciences
Asan Medical Center
Thomas Jefferson University
Children's Hospital of Fudan University
M.D. Anderson Cancer Center
University of Illinois at Chicago
Centre Oscar Lambret
Rigshospitalet, Denmark
Instituto de Investigacion Sanitaria INCLIVA
Marmara University
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center